Multiple Sclerosis: Diagnosis and Treatment Management in Allopathy

This article summarizes the literature related to the pathogenic mechanisms and treatment options for multiple sclerosis, an autoimmune, demyelinating disorder of the central nervous system. The etiology of MS is not known, both genetic and environmental factors are known to play a role. The risk factor that is strongly associated with MS Epstein-Barr infection. Other factors subjected to modification are childhood obesity, smoking and vitamin deficient individuals. Vitamin D deficiency as a risk factor has been proposed to explain the increase in prevalence of MS with increase in the latitude. The pathogenesis involves a response which is mediated by T-cell directed against myelin and other similar proteins. The function of B-cells in the disease process is not known. Recent advancements in the understanding of multiple sclerosis has led to development of disease modifying therapies, which in turn has led to a decrease in severity of the disease and relapse rates. Disease modifying therapies act by modulating or suppressing the immune system. Moreover, several drugs have shown effectiveness in certain studies. A number of treatment options have now become available making treatment of MS possible. The management of MS is divided into 3 categories:

Treatment of Exacerbations

Slowing disease progression with Disease modifying therapies

Symptomatic treatment